IMRX Stock Up on FDA's Orphan Drug Tag for Pancreatic Cancer Drug

Zacks Oct 16 21:35

12 Health Care Stocks Moving In Tuesday's Intraday Session

BenzingaOct 16 00:32

Immuneering Says Potential Pancreatic Cancer Treatment Gets FDA Orphan Drug Designation

MT NewswiresOct 15 21:16

Notable Labs NTBL Chapter 7 Bankruptcy; Immuneering IMRX Orphan Drug Designation

BioPharmCatalystOct 15 21:06

Express News | Immuneering Corp: Imm-1-104 Is Currently Being Evaluated in a Phase 2a Clinical Trial

BreakingsOct 15 20:03

Express News | Immuneering Granted Orphan Drug Designation for Imm-1-104 by FDA in the Treatment of Pancreatic Cancer

BreakingsOct 15 20:00